Critical Workers Compensation Pharmacy Review Signals Important California Drug Policy Changes in 2026
September 2, 2026 | Sacramento, CA — MedLegalNews.com — California’s workers’ compensation pharmaceutical policy has entered another important review cycle following the July 15 meeting of the Division of Workers’ Compensation Pharmacy and Therapeutics Committee. The committee provides advice to the DWC Administrative Director concerning the workers’ compensation drug formulary and related pharmaceutical treatment policies. […]










